Vision problems, eye redness

Case Study: Addressing Chronic Ocular Complications with coMra Therapy

This case study examines a 55-year-old female patient with a significant ocular history, beginning with a herpetic infection in her left eye at the age of ten. By age 30, the patient required a penetrating keratoplasty – a surgical procedure where a donor cornea replaces the patient's own – due to severe corneal opacification.

Over the past year, the patient reported a decline in visual acuity in her left eye, accompanied by persistent redness and discomfort. Despite being prescribed corticosteroid eyedrops by another ophthalmologist three months prior, the patient experienced no improvement.

Clinical Examination and Diagnosis

Upon examination, the patient’s visual acuity was measured at 20/25 in the right eye and 20/60 in the left eye. Diagnostic findings included:

* Endothelial Pigment: Pigmentation was discovered in the bottom layer of the corneal cells. In a healthy cornea, this layer should be clear of pigment. * Intraocular Pressure: Measured at 16 mmHg in the right eye and 14 mmHg in the left. * Surgical History: The patient had a previous superior iridectomy, a procedure performed during her earlier keratoplasty to create a small opening in the iris, preventing potential angle-closure glaucoma. * Conjunctival Hyperemia: Visible redness of the conjunctiva was noted. * Tear Film Breakup Time (TBUT): The patient’s TBUT was less than eight seconds. A TBUT of under 10 seconds is a clinical indicator of dry eye syndrome. * Keratitis and Opacification: The patient presented with mild keratitis and mild opacification across the cornea of the left eye.

Treatment Protocol and Results

The patient underwent a treatment regimen consisting of Ophthalmology 14, administered once per week for a total of 12 treatments over a three-month period. This protocol utilized the coMra Pro device with the Delta 905 laser, integrated alongside acupuncture and dietary recommendations.

Following the 12-week course of coMra therapy, the results were as follows:

* Visual Acuity: The patient’s left eye improved from 20/60 to 20/50, representing a one-line improvement on the eye chart. * Conjunctival Hyperemia: The redness was completely resolved. * Tear Film Stability: The breakup time improved from less than eight seconds to 13 seconds in both eyes, moving the patient closer to the optimal range of 15 seconds or higher. * Resolution of Keratitis: The mild keratitis was no longer present. * Patient Feedback: The patient reported a significant improvement in her general ocular condition.

A follow-up examination conducted six months after the conclusion of the treatment confirmed that these improvements were maintained.

Clinical Integration

This case highlights the efficacy of integrating coMra therapy into a broader clinical practice. We extend our gratitude to Dr. Pena, an ophthalmologist specializing in cataract and refractive surgery. Dr. Pena is dedicated to public health initiatives, providing essential eye care to underserved communities globally. In his practice, he combines homeopathy and traditional Chinese medicine with microcurrent therapy and coMra therapy to treat complex ocular conditions, ensuring a better quality of life for his patients.

For those interested in learning more, please refer to the links provided in our newsletter to explore Dr. Pena’s published works.